Nirvana Sciences, Inc. — Form D
Nirvana Sciences, Inc. of RESEARCH TRIANGLE PARK, NC, a company, filed a Form D exempt-offering notice with the SEC on 2021-05-26. The offering totals $1.0M, of which $867K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2021-05-26
- Form: D
- Accession: 0001623353-21-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $867K
- Remaining: $133K
- Investors: 8
- Date of first sale: 2021-05-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-400762
Issuer
- Name: Nirvana Sciences, Inc.
- CIK: 0001623353
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 7020 Kit Creek Road, RESEARCH TRIANGLE PARK, NC, 27709
- Phone: 919-354-1053
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Wayne Brinster | Director | New York, NY |
| Lisa Cooper | Director | Leawood, KS |
| RUSSELL THOMAS | Director | CHICAGO, IL |
| Richard West | Director | new york, NY |
| RUSSELL THOMAS | Executive Officer | CHICAGO, IL |
| RUSSELL THOMAS | Promoter | CHICAGO, IL |
Other filings by this issuer (1)
More